BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24607147)

  • 1. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.
    Medway CW; Abdul-Hay S; Mims T; Ma L; Bisceglio G; Zou F; Pankratz S; Sando SB; Aasly JO; Barcikowska M; Siuda J; Wszolek ZK; Ross OA; Carrasquillo M; Dickson DW; Graff-Radford N; Petersen RC; Ertekin-Taner N; Morgan K; Bu G; Younkin SG
    Mol Neurodegener; 2014 Mar; 9():11. PubMed ID: 24607147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
    Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
    JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease.
    Fan K; Francis L; Aslam MM; Bedison MA; Lawrence E; Acharya V; Snitz BE; Ganguli M; DeKosky ST; Lopez OL; Feingold E; Kamboh MI
    Neurobiol Aging; 2023 Feb; 122():107-111. PubMed ID: 36528961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
    Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
    J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
    Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
    J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease.
    Asanomi Y; Shigemizu D; Miyashita A; Mitsumori R; Mori T; Hara N; Ito K; Niida S; Ikeuchi T; Ozaki K
    Mol Med; 2019 Jun; 25(1):20. PubMed ID: 31216982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.
    Wijsman EM; Pankratz ND; Choi Y; Rothstein JH; Faber KM; Cheng R; Lee JH; Bird TD; Bennett DA; Diaz-Arrastia R; Goate AM; Farlow M; Ghetti B; Sweet RA; Foroud TM; Mayeux R;
    PLoS Genet; 2011 Feb; 7(2):e1001308. PubMed ID: 21379329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
    Rao S; Ghani M; Guo Z; Deming Y; Wang K; Sims R; Mao C; Yao Y; Cruchaga C; Stephan DA; Rogaeva E
    Neurobiol Aging; 2018 Jun; 66():178.e1-178.e8. PubMed ID: 29395286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese.
    Ma XY; Yu JT; Tan MS; Sun FR; Miao D; Tan L
    Neurobiol Aging; 2014 Feb; 35(2):443.e17-21. PubMed ID: 24018213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.
    Grupe A; Abraham R; Li Y; Rowland C; Hollingworth P; Morgan A; Jehu L; Segurado R; Stone D; Schadt E; Karnoub M; Nowotny P; Tacey K; Catanese J; Sninsky J; Brayne C; Rubinsztein D; Gill M; Lawlor B; Lovestone S; Holmans P; O'Donovan M; Morris JC; Thal L; Goate A; Owen MJ; Williams J
    Hum Mol Genet; 2007 Apr; 16(8):865-73. PubMed ID: 17317784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
    Hu X; Pickering E; Liu YC; Hall S; Fournier H; Katz E; Dechairo B; John S; Van Eerdewegh P; Soares H;
    PLoS One; 2011 Feb; 6(2):e16616. PubMed ID: 21390209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
    Naj AC; Jun G; Reitz C; Kunkle BW; Perry W; Park YS; Beecham GW; Rajbhandary RA; Hamilton-Nelson KL; Wang LS; Kauwe JS; Huentelman MJ; Myers AJ; Bird TD; Boeve BF; Baldwin CT; Jarvik GP; Crane PK; Rogaeva E; Barmada MM; Demirci FY; Cruchaga C; Kramer PL; Ertekin-Taner N; Hardy J; Graff-Radford NR; Green RC; Larson EB; St George-Hyslop PH; Buxbaum JD; Evans DA; Schneider JA; Lunetta KL; Kamboh MI; Saykin AJ; Reiman EM; De Jager PL; Bennett DA; Morris JC; Montine TJ; Goate AM; Blacker D; Tsuang DW; Hakonarson H; Kukull WA; Foroud TM; Martin ER; Haines JL; Mayeux RP; Farrer LA; Schellenberg GD; Pericak-Vance MA; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barnes LL; Beach TG; Becker JT; Beekly D; Bigio EH; Bowen JD; Boxer A; Burke JR; Cairns NJ; Cantwell LB; Cao C; Carlson CS; Carney RM; Carrasquillo MM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Dick M; Dickson DW; Duara R; Faber KM; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Growdon JH; Hamilton RL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jicha GA; Jin LW; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lin CF; Lopez OL; Lyketsos CG; Mack WJ; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Murrell JR; Olichney JM; Pankratz VS; Parisi JE; Paulson HL; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reisberg B; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Valladares O; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
    JAMA Neurol; 2014 Nov; 71(11):1394-404. PubMed ID: 25199842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.
    Reitz C; Jun G; Naj A; Rajbhandary R; Vardarajan BN; Wang LS; Valladares O; Lin CF; Larson EB; Graff-Radford NR; Evans D; De Jager PL; Crane PK; Buxbaum JD; Murrell JR; Raj T; Ertekin-Taner N; Logue M; Baldwin CT; Green RC; Barnes LL; Cantwell LB; Fallin MD; Go RC; Griffith P; Obisesan TO; Manly JJ; Lunetta KL; Kamboh MI; Lopez OL; Bennett DA; Hendrie H; Hall KS; Goate AM; Byrd GS; Kukull WA; Foroud TM; Haines JL; Farrer LA; Pericak-Vance MA; Schellenberg GD; Mayeux R;
    JAMA; 2013 Apr; 309(14):1483-92. PubMed ID: 23571587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
    Martin ER; Lai EH; Gilbert JR; Rogala AR; Afshari AJ; Riley J; Finch KL; Stevens JF; Livak KJ; Slotterbeck BD; Slifer SH; Warren LL; Conneally PM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
    Am J Hum Genet; 2000 Aug; 67(2):383-94. PubMed ID: 10869235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
    Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
    Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
    Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.